Apnimed Awakens: Wild IPO Ride Ends with 56% First-Day Gain

Apnimed (APMD US) priced 12.0 million shares, increasing the offering from the originally proposed 10.0 million shares, at $16.00 per share, the high end of its marketed range. The upsizing reflected robust institutional demand built during the marketing process, where IPO Boutique channel checks indicated the transaction was multiple-times oversubscribed and well supported by both dedicated healthcare investors and new crossover accounts.

The stock opened at $22.00, representing a 37.5% gain over the IPO price, but the early optimism quickly gave way to profit-taking. Heavy selling pressure emerged almost immediately, resulting in a trading halt within the first ten minutes of the session. Shares subsequently fell as low as $16.12, nearly retracing the entire opening premium and trading just pennies above the IPO price.

After stabilizing around that level for roughly forty minutes, sentiment shifted dramatically. Institutional buyers stepped in with conviction, sparking a steady rally throughout the remainder of the session. Momentum accelerated during the afternoon, ultimately lifting the stock to an intraday high of $29.15 before shares settled at $25.00, representing a 56.3% gain from the IPO price.

The dramatic swing from a near-flat trade to an 80%+ intraday gain underscores the increasingly volatile nature of successful biotech IPOs, particularly those with limited public floats.

Apnimed possesses characteristics that many institutional investors favor. Its lead product candidate, Oxnimbi (AD109), has successfully completed Phase 3 clinical trials and is currently under FDA review, making it materially less risky than many preclinical or Phase 1 biotechnology issuers. While regulatory uncertainty always remains, the completion of pivotal trials significantly reduces development risk.

Finally, the structure of the offering likely amplified the aftermarket move. With a relatively small public float and shares concentrated among long-term institutional investors, available supply remained limited. This “clubby” ownership profile often contributes to outsized price swings as incremental buying pressure competes for a limited number of freely tradable shares.

 

Jersey Mike’s Subs Inc. (JMKE): A Brand That Couldn’t Outrun Its Valuation

Jersey Mike’s Subs (JMKE US) brought an anticipated consumer IPOs to market on Thursday, but what looked like a textbook bookbuilding process ultimately turned into another difficult debut for a private equity-backed issuer. Despite overwhelming investor demand leading into pricing, the stock opened below its IPO price following an unusually lengthy opening auction and never managed to reclaim the offering price during its first session.

The company priced its full-size offering of 43.48 million shares at $23.00, the midpoint of the $21.00-$25.00 marketing range, raising approximately $1.0 billion in gross proceeds. The transaction valued Jersey Mike’s at roughly $7.3 billion and marked one of the larger consumer IPOs of the year.

Ironically, the disappointing debut did not stem from a lack of investor interest. According to IPO Boutique channel checks, the transaction was more than 15-times oversubscribed, with the order book heavily supported by anchor allocations to long-only institutional investors and sector-dedicated funds. Approximately 20% of accounts ultimately received no allocation at all, underscoring the depth of demand generated during the marketing process.

However, the tone changed noticeably during the final stages of the roadshow. Market participants observed that underwriters became increasingly quiet regarding pricing expectations during the day leading into pricing, a subtle but often meaningful signal that valuation discussions were becoming more challenging. While demand remained robust, investors appeared increasingly disciplined on price rather than willing to chase the deal at any valuation.

When trading finally commenced, shares opened at $21.00, an 8.7% discount to the IPO price.

The stock briefly attempted to recover, reaching an intraday high of $22.88 within the first thirty minutes of trading after touching an early low of $20.63. The rebound proved short-lived, however, as sellers regained control throughout the afternoon. Jersey Mike’s finished its inaugural session at $21.63, representing a 6.0% decline from the IPO price.

The stock did rally late in the afternoon during Friday’s session to as high as $23.21 and closed the week above issue price at $23.00.

While the deal finished the week flat, one cannot help but wonder whether the underperformance on day one was due to the issuer prioritizing reaching the psychological milestone of a $1.0 billion capital raise—achieved by selling 43.5 million shares at $23.00—over leaving sufficient upside for aftermarket investors. Had the company and its selling shareholders been willing to sacrifice a modest amount of proceeds through a lower IPO price, the aftermarket performance may have looked considerably different.

Reformation (REF): Disciplined Pricing Helps Fashion Brand Deliver a Steady Market Debut

Consumer apparel company Reformation (REF US) entered the public markets Thursday with a debut that favored stability over spectacle. The company priced its 14.1 million share IPO at $15.00, the low end of its marketed $15-$17 range, opened exactly at the offering price, briefly traded as high as $15.75, and ultimately closed its first session at $15.08, a modest 0.5% gain.

Although the IPO lacked the explosive first-day appreciation often associated with high-profile consumer brands, the outcome should nevertheless be viewed as a successful execution. In a market that has become increasingly valuation sensitive, underwriters opted for discipline rather than attempting to maximize proceeds. That decision allowed the stock to trade in an orderly fashion throughout the session and finish above issue price despite limited speculative momentum.

Following a brief early push to $15.75, shares spent most of the trading day fluctuating near the IPO price. The stock did rally during REF’s second session to as high as as $16.35 and closed the week at $16.22.

---